FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2047820537> ?p ?o ?g. }

• W2047820537 endingPage "509" @default.
• W2047820537 startingPage "491" @default.
• W2047820537 abstract "Anthracycline antibiotics remain among the most potent anticancer drugs, but their efficacy is limited by the development of a dose-dependent irreversible cardiomyopathy and by the emergence of clones of tumor cells resistant to the effects of the drug. Modifications of the basic anthracycline structure have resulted in molecules that may share the activity of the parent compound, with amelioration of some toxicities, absence of cross-resistance, or activity against tumors insensitive to the parent drug. Epirubicin has a unique metabolic pathway, glucuronidation, that may result in more rapid plasma clearance and reduced toxicity as compared with doxorubicin. Epirubicin has demonstrated comparable activity to doxorubicin in breast cancer, with possibly reduced toxicity. Idarubicin is of interest because of its cytotoxic activity when given orally. Idarubicin has prolonged retention in the plasma and has equal cytotoxic activity to the parent compound. Idarubicin has demonstrated activity against acute leukemia and breast cancer; in the latter tumor category, some doxorubicin-resistant tumors have responded. Esorubicin is of interest because of its nearly absent cardiac toxicity. This agent has some activity against solid tumors and is currently being clinically tested. Aclacinomycin A is an anthracycline in which a trisaccharide is substituted for the aminosugar. Aclacinomycin A and the related compound marcellomycin are of interest as both cytotoxic and differentiating agents. Menogaril is an anthracycline with the aminosugar on the D ring; it does not exhibit cross-resistance with doxorubicin or cardiotoxicity. Mitoxantrone is a compound that is related to the anthracyclines but has a different mechanism of action. This agent has significant activity against acute leukemia and breast cancer and is currently being compared with doxorubicin. Amsacrine is another compound related to the anthracyclines that possesses major activity against acute leukemias. Minor modifications of the anthracycline molecule have had major impact on the biologic activity of these drugs. New anthracycline analogues with up to 100 times the potency of currently available anthracyclines are being developed for clinical testing, and these complex molecules retain a nearly unlimited potential for structural modification." @default.
• W2047820537 created "2016-06-24" @default.
• W2047820537 creator A5071579916 @default.
• W2047820537 creator A5074870039 @default.
• W2047820537 creator A5089619585 @default.
• W2047820537 date "1986-09-10" @default.
• W2047820537 modified "2023-09-23" @default.
• W2047820537 title "Phase I and II Agents in Cancer Therapy: I. Anthracyclines and Related Compounds" @default.
• W2047820537 cites W1530821577 @default.
• W2047820537 cites W1821896339 @default.
• W2047820537 cites W1828224642 @default.
• W2047820537 cites W1888375872 @default.
• W2047820537 cites W1913776611 @default.
• W2047820537 cites W1965330917 @default.
• W2047820537 cites W1967286759 @default.
• W2047820537 cites W1970905857 @default.
• W2047820537 cites W1971390843 @default.
• W2047820537 cites W1977144190 @default.
• W2047820537 cites W1981292619 @default.
• W2047820537 cites W1983407636 @default.
• W2047820537 cites W1985320959 @default.
• W2047820537 cites W1992536259 @default.
• W2047820537 cites W1992786087 @default.
• W2047820537 cites W2001653908 @default.
• W2047820537 cites W2002946010 @default.
• W2047820537 cites W2004031188 @default.
• W2047820537 cites W2007233235 @default.
• W2047820537 cites W2010291543 @default.
• W2047820537 cites W2014029165 @default.
• W2047820537 cites W2014084640 @default.
• W2047820537 cites W2016254453 @default.
• W2047820537 cites W2016413248 @default.
• W2047820537 cites W2017959940 @default.
• W2047820537 cites W2024049231 @default.
• W2047820537 cites W2029692863 @default.
• W2047820537 cites W2031487826 @default.
• W2047820537 cites W2031590373 @default.
• W2047820537 cites W2034254653 @default.
• W2047820537 cites W2034982335 @default.
• W2047820537 cites W2035215935 @default.
• W2047820537 cites W2036452587 @default.
• W2047820537 cites W2040246951 @default.
• W2047820537 cites W2042525042 @default.
• W2047820537 cites W2042849799 @default.
• W2047820537 cites W2043336442 @default.
• W2047820537 cites W2044158833 @default.
• W2047820537 cites W2044475548 @default.
• W2047820537 cites W2045930772 @default.
• W2047820537 cites W2046852462 @default.
• W2047820537 cites W2049248176 @default.
• W2047820537 cites W2049290929 @default.
• W2047820537 cites W2050209551 @default.
• W2047820537 cites W2053572223 @default.
• W2047820537 cites W2054534305 @default.
• W2047820537 cites W2055307705 @default.
• W2047820537 cites W2057758189 @default.
• W2047820537 cites W2057914808 @default.
• W2047820537 cites W2059884461 @default.
• W2047820537 cites W2069393813 @default.
• W2047820537 cites W2070302413 @default.
• W2047820537 cites W2073226603 @default.
• W2047820537 cites W2075240964 @default.
• W2047820537 cites W2081540685 @default.
• W2047820537 cites W2086088589 @default.
• W2047820537 cites W2086397676 @default.
• W2047820537 cites W2103674103 @default.
• W2047820537 cites W2153156872 @default.
• W2047820537 cites W2165145228 @default.
• W2047820537 cites W2229490770 @default.
• W2047820537 cites W2254334874 @default.
• W2047820537 cites W2277177857 @default.
• W2047820537 cites W2290672777 @default.
• W2047820537 cites W2325777487 @default.
• W2047820537 cites W2333082154 @default.
• W2047820537 cites W2347931651 @default.
• W2047820537 cites W2403113009 @default.
• W2047820537 cites W2417172377 @default.
• W2047820537 cites W2419673119 @default.
• W2047820537 cites W2883269896 @default.
• W2047820537 cites W371159634 @default.
• W2047820537 cites W39575423 @default.
• W2047820537 cites W4233358291 @default.
• W2047820537 cites W4250436201 @default.
• W2047820537 cites W4252141322 @default.
• W2047820537 cites W4301221098 @default.
• W2047820537 cites W4301697304 @default.
• W2047820537 cites W835340358 @default.
• W2047820537 cites W8682914 @default.
• W2047820537 cites W2040076753 @default.
• W2047820537 doi "https://doi.org/10.1002/j.1552-4604.1986.tb02942.x" @default.
• W2047820537 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2944917" @default.
• W2047820537 hasPublicationYear "1986" @default.
• W2047820537 type Work @default.
• W2047820537 sameAs 2047820537 @default.
• W2047820537 citedByCount "39" @default.
• W2047820537 countsByYear W20478205372014 @default.
• W2047820537 countsByYear W20478205372015 @default.
• W2047820537 countsByYear W20478205372017 @default.

• next